Implantable microelectrodes that can safely capture brain activity are critical in neuroscience technologies. In a recent study, researchers from South Korea have developed a new class of polymer-carbon nanotube (CNT) based hybrid microelectrode arrays, which combine high electrical conductivity with mechanical softness. These advanced electrodes enable stable recording of brain signals while limiting inflammation and damage to brain tissue—paving the way for safer and smarter brain-computer interfaces.

A research team led by Prof. PAN Ding, Associate Professor from the Departments of Physics and Chemistry, and Dr. LI Shuo-Hui, Research Assistant Professor from the Department of Physics at the Hong Kong University of Science and Technology (HKUST), has developed a novel direct sampling method based on deep generative models. This method enables efficient sampling of the Boltzmann distribution across a continuous temperature range. 

Patients are increasingly turning to AI for medical information and even advice, but how should they approach using AI-powered services? A new study published in the peer-reviewed journal, Future Science OA, provides insight into this question for the fast-moving field of blood cancer.

 

A team of scientists at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) has created a protein-based therapeutic tool  that could change the way we treat diseases caused by harmful or unnecessary cells. The new tool, published in Nature Biomedical Engineering, involves a synthetic protein called Crunch, short for Connector for Removal of Unwanted Cell Habitat. Crunch uses the body’s natural waste removal system to clear out specific target cells, offering hope for improved treatments for cancer, autoimmune diseases, and other diseases where harmful cells cause damage.

Researchers at the Antimicrobial Resistance (AMR) interdisciplinary research group of the Singapore-MIT Alliance for Research and Technology (SMART), Massachusetts Institute of Technology’s (MIT) research enterprise in Singapore, have developed a powerful tool capable of scanning thousands of biological samples to detect transfer ribonucleic acid (tRNA) modifications — tiny chemical changes to RNA molecules that help control how cells grow, adapt to stress and respond to diseases such as cancer and antibiotic‑resistant infections.